BerGenBio jobs and careers
Bergen, Hordaland, Norway
About BerGenBio
BerGenBio: Developing first-in-class AXL inhibitors for aggressive diseases, including advanced, treatment resistant cancers
Founded in 2007 by David Micklem and James Lorens.
- Founded
- 2007
- Employees
- 11 to 50
- Total funding
- $183.4M
- Headquarters
- Bergen
Leadership
The top of BerGenBio's org chart, with how many people report into each leader.
GM
Gayle Mills
Chief Business Officer
RS
Rune Skeie
CFO
Board
SB
Sally Bennet
Director
AT
Anders Tullgren
Chair
JH
John Heymach
Scientific Advisor
DB
Debra Barker
Director
EF
Enriqueta Felip
Scientific Advisor
TM
Tony Mok
Scientific Advisor
Jobs at BerGenBio
No open positions right now. Explore more companies on TheJobsMap.